Investor
TRV GP V, LLC
CIK 0001990717 · filed 2026-05-07 · SEC filing
13F book
$401M
Positions
3
Largest name
55.7%
Rapport Therapeutics, Inc. · RAPP
Est. mark
−$28.2M
Price effect on 3 names still held. Flow −$0.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | RAPP | 7.14M | $223.3M | 55.7% | $6.78M | Held |
| Septerna, Inc. | SEPN | 6.22M | $149.4M | 37.2% | −$23.9M | Held |
| Maze Therapeutics, Inc. | MAZE | 950.8K | $28.4M | 7.1% | −$11M | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.